Search results
Found 12698 matches for
Researchers at the University of Oxford led by DPAG's Professor Peter Robbins are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die when oxygen levels in their arterial blood fall to levels that are too low to support life.
Samira Lakhal-Littleton
BSc DPhil Samira Lakhal-Littleton - Associate Professor of Cell Physiology and MRC Senior Non-Clinical Research Fellow
David Paterson
D.Phil (Oxon), D.Sc HonDUniv (WAust) HonLLD (Otago) Hon FRSNZ David Paterson - Head of Department
Duncan Sparrow
PhD Duncan Sparrow - Associate Professor and BHF Senior Basic Science Research Fellow
